Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma

• DOI: 10.1186/s12876-018-0899-3
• Publication Date: 2018-11-12T08:09:18Z
• Authors: Huiyong Wu; Wei Zhao; Jianbo Zhang; Jianjun Han; Shuguang Liu
• Keywords: Adult; Male; Carcinoma, Hepatocellular; Hepatocellular carcinoma; Computed Tomography Angiography; Portal vein tumor embolus; RC799-869; Transarterial chemoembolization; 03 medical and health sciences; Hepatic Artery; 0302 clinical medicine; Hepatic arterioportal shunts; Humans; Aged; Aged, 80 and over; Liver Neoplasms; Diseases of the digestive system. Gastroenterology; Middle Aged; Neoplastic Cells, Circulating; Embolization, Therapeutic; 3. Good health; Portal System; Arteriovenous Fistula; Female; Research Article

Hepatic arterioportal shunt (A-P shunt) is defined as the direct blood flow established between hepatic artery and portal venous system; it frequently observed in patients with hepatocellular carcinoma (HCC). Clinically, important to diagnose HCC associated A-P shunts, may impact treatment strategy of patients. In present study, we described imaging findings shunts discussed treatments such From findings, also potential cause shunts. Clinical data (n = 560), admitted hospital April 2012 2014, were reviewed. angiography was used examine presence Of 137 grading performed, statistical analysis different grades clinical characteristics performed. The confirmed that 99 had typical (Grade 1–3), 38 atypical Embolization main treat which liquid embolic agents appeared provide a better outcome. correlation showed vein tumor thrombus significantly (p < 0.001, Spearman coefficient 0.816 ± 0.043). We characterized proposed for treating various levels supported hypothesis formation caused by thrombus.